← Back to Search

Behavioral Intervention

Social Media Messages Intervention Group for Human Immunodeficiency Virus Infection (MAP Trial)

N/A
Waitlist Available
Led By Jacob J van den Berg, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

MAP Trial Summary

This trial will test an intervention to increase use of treatment as prevention and pre-exposure prophylaxis among Black/African American and Hispanic/Latino MSM in the United States.

MAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
treatment as prevention and pre-exposure prophylaxis uptake
Secondary outcome measures
treatment as prevention and pre-exposure prophylaxis knowledge, attitudes, and behavioral intentions

MAP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Social Media Messages Intervention GroupExperimental Treatment1 Intervention
Participants randomized to this condition will have access to a newly developed, culturally-tailored interactive website and theoretically-grounded social media messages.
Group II: Website Only GroupActive Control1 Intervention
Participants randomized to this condition will have access to a newly developed, culturally-tailored interactive website only.

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
456 Previous Clinical Trials
558,092 Total Patients Enrolled
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,476,892 Total Patients Enrolled
Jacob J van den Berg, PhDPrincipal InvestigatorBrown University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media
Jacob J. van den Berg, PhD 2017. "Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03404531.
All > Aids
~22 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top